Vertex Pharmaceuticals, Inc. (VRTX)
NGS · Common · CUSIP 92532F100
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for VRTX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
92532F100
Market Cap
Large Cap
Business: Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative new medicines so people with serious diseases can lead better lives. Founded in 1989 in Cambridge, MA, Vertex today has research and development sites and commercial offices around the world in the United States, Canada, Europe and Australia.

Company Contact

CEO
Reshma Kewalramani
CFO
Charles Wagner
Headquarters
50 Northern Avenue, Boston, MA 02210
Phone
617-341-6100
Investor Relations
Susie Lisa · 617-341-6108 · investorinfo@vrtx.com
SEC EDGAR Filings
View filings »